Clinical data on TG01 will be presented at ASCO

Clinical data from the Phase I/II trial of TG01 in resected pancreatic cancer will be presented at the American Society of Clinical Oncology (ASCO) meeting, announces Targovax. Read more

7 Apr 2017 10:46 News